SuperworthViatris market cap VTRS
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $20.7B
- Highest close in our data
- $21.4B
- Oct 2026
Viatris is worth $20.7B at the close on Oct 23, 2026, at $18.00 a share.
That is up 71% over the last year and up 28% over five years.
Its highest close in our data was $21.4B in Oct 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $20.7B | $14.4B | $21.4B | +46% |
| 2025 | $14.2B | $9B | $14.7B | −5% |
| 2024 | $14.9B | $12.1B | $16.2B | +15% |
| 2023 | $13B | $10.5B | $14.8B | −4% |
| 2022 | $13.5B | $10.3B | $18.4B | −18% |
| 2021 | $16.4B | $14.8B | $19.3B | n/a |
Against its peers
Companies in Healthcare nearest Viatris' size, closest first, today.
| Company | Market cap |
|---|---|
| VTRSViatris | $20.7B |
| THCTenet Healthcare | $21.6B |
| STESTERIS | $22.6B |
| ZBHZimmer Biomet | $18.8B |
| MEDPMedpace | $18.7B |
| INCYIncyte | $23.5B |
| RVTYRevvity | $17.7B |
| UTHRUnited Therapeutics | $25.2B |
| LHLabcorp | $26.7B |
| DGXQuest Diagnostics | $26.7B |
| EXELExelixis | $16B |
| Peer median | $22.1B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Viatris
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.